ProfessorStephenMacMahon

Faculty of Medicine, School of Public Health

Chair of Global Health

Contact

Location

Sir Alexander Fleming BuildingSouth Kensington Campus

Summary

Stephen is one of the founders of The George Institute for Global Health, an architect of its global expansion and currently holds the position of Principal Director of The George Institute for Global Health (worldwide).

He holds professorial appointments in medicine at UNSW Sydney and Chair of Global Health, Faculty of Medicine, Imperial College of London. Stephen is an international authority on the causes, prevention and treatment of cardiovascular diseases and has a special interest is the management of chronic and complex conditions in resource-poor settings, particularly in the Asia-Pacific region.

In addition to his Institute and university appointments, Stephen has held several external appointments, including former Chair of the International Scientific Board of the UK BioBank. He is also Executive Chair of George Clinical Pty Ltd, a wholly owned subsidiary of The George Institute.

Stephen has published more than 300 scientific papers and delivered more than 200 invited lectures. For his work in the field of cardiovascular disease, he has received numerous awards, fellowships and honours from various governments, universities and learned societies.

Publications

Journals

Radhoe SP, Boersma E, Bertrand M, et al.Radhoe SP, Boersma E, Bertrand M, Remme W, Ferrari R, Fox K, MacMahon S, Chalmers J, Simoons ML, Brugts JJ close, 2022, The Effects of a Perindopril-Based Regimen in Relation to Statin Use on the Outcomes of Patients with Vascular Disease: a Combined Analysis of the ADVANCE, EUROPA, and PROGRESS Trials, Cardiovascular Drugs and Therapy, ISSN:0920-3206

Collaborat CTTC, Reith C, Baigent C, et al.Collaborat CTTC, Reith C, Baigent C, Blackwell L, Emberson J, Spata E, Davies K, Halls H, Holland L, Wilson K, Armitage J, Harper C, Preiss D, Roddick A, Keech A, Simes J, Collins R, Fulcher J, Herrington WG, Kirby A, Mihaylova B, O'Connell R, Banks E, Blastland M, Evans S, Temple R, Weissberg P, Wittes J, Blazing M, Braunwald E, de Lemos J, Murphy S, Pedersen TR, Pfeffer M, White H, Wiviott S, Clearfield M, Downs JR, Gotto Jr A, Weis S, Fellstroem B, Holdaas H, Jardine A, Gordon D, Davis B, Furberg C, Grimm R, Pressel S, Probstfield J, Rahman M, Simpson L close, 2022, Effect of statin therapy on muscle symptoms: an individual participant data meta-analysis of large-scale, randomised, double-blind trials, Lancet, Vol:400, ISSN:0140-6736, Pages:832-845

Nazarzadeh M, Bidel Z, Canoy D, et al.Nazarzadeh M, Bidel Z, Canoy D, Copland E, Bennett DA, Dehghan A, Davey Smith G, Holman RR, Woodward M, Gupta A, Adler AI, Wamil M, Sattar N, Cushman WC, McManus RJ, Teo K, Davis BR, Chalmers J, Pepine CJ, Rahimi K, Blood Pressure Lowering Treatment Trialists' Collaboration close, 2022, Blood pressure-lowering treatment for prevention of major cardiovascular diseases in people with and without type 2 diabetes: an individual participant-level data meta-analysis, The Lancet Diabetes and Endocrinology, Vol:10, ISSN:2213-8595, Pages:645-654

Patel A, Ojji D, de Silva HA, et al.Patel A, Ojji D, de Silva HA, MacMahon S, Rodgers A close, 2022, Polypills for the prevention of cardiovascular disease: a framework for wider use, Nature Medicine, Vol:28, ISSN:1078-8956, Pages:226-229

Anderson CS, Rodgers A, de Silva HA, et al.Anderson CS, Rodgers A, de Silva HA, Martins SO, Klijn CJM, Senanayake B, Freed R, Billot L, Arima H, Thang NH, Zaidi WAW, Kherkheulidze T, Wahab K, Fisher U, Lee T-H, Chen C, Pontes-Neto O, Robinson T, Wang J, Naismith S, Song L, Schreuder FH, Lindley R, Woodward M, MacMahon S, Salman RA-S, Chow CK, Chalmers J close, 2022, Triple Therapy Prevention of Recurrent Intracerebral Disease Events Trial: Rationale, design and progress, International Journal of Stroke, ISSN:1747-4930

More Publications